Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)

Market Cap	1.18B
Revenue (ttm)	56.97M
Net Income (ttm)	-111.06M
Shares Out	239.11M
EPS (ttm)	-0.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,000
Average Volume	63,860
Open	4.990
Previous Close	4.970
Day's Range	4.930 - 5.000
52-Week Range	3.200 - 14.020
Beta	-1.14
RSI	50.80
Earnings Date	May 28, 2025

About HKG:6922

Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, develops, produces, and sells minimally invasive interventional cryotherapy products in the People’s Republic of China. The company develops products in two areas: vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases. Its products include the Bladder Cryoablation System, a cryotherapy device for...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 276
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6922

Financial Performance

In 2024, HKG:6922's revenue was 53.53 million, an increase of 30.72% compared to the previous year's 40.95 million. Losses were -104.37 million, 7.06% more than in 2023.

Financial numbers in CNY